Sign in
PBM Stock Price, Chart, Stats & News
Psyence Biomedical Ltd.
Save
59,910
Market cap
–
Current P/E
–
Forward P/E
PBM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -4.78% |
ROE | -11.53% |
D/E | – |
Interest coverage ratio | -411.78x |
PBM valuation
P/E | – |
P/S | – |
P/B | 0.32x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -0.06x |
EV multiple | -12.02x |
About
Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study.
Similar securities
Based on sector and market capitalization
Report issue